BRCA2 c.4106del ;(p.S1369Lfs*5)

Variant ID: 13-32912598-TC-T

NM_000059.3(BRCA2):c.4106del;(p.S1369Lfs*5)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Extended gene panel testing in lobular breast cancer.

Familial Cancer
van Veen, Elke M EM; Evans, D Gareth DG; Harkness, Elaine F EF; Byers, Helen J HJ; Ellingford, Jamie M JM; Woodward, Emma R ER; Bowers, Naomi L NL; Wallace, Andrew J AJ; Howell, Sacha J SJ; Howell, Anthony A; Lalloo, Fiona F; Newman, William G WG; Smith, Miriam J MJ
Publication Date: 2022-04

Variant appearance in text: BRCA2: 4106delC
PubMed Link: 33763779
Variant Present in the following documents:
  • 10689_2021_Article_241.pdf
View BVdb publication page



Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.

The Lancet. Oncology
Copson, Ellen R ER; Maishman, Tom C TC; Tapper, Will J WJ; Cutress, Ramsey I RI; Greville-Heygate, Stephanie S; Altman, Douglas G DG; Eccles, Bryony B; Gerty, Sue S; Durcan, Lorraine T LT; Jones, Louise L; Evans, D Gareth DG; Thompson, Alastair M AM; Pharoah, Paul P; Easton, Douglas F DF; Dunning, Alison M AM; Hanby, Andrew A; Lakhani, Sunil S; Eeles, Ros R; Gilbert, Fiona J FJ; Hamed, Hisham H; Hodgson, Shirley S; Simmonds, Peter P; Stanton, Louise L; Eccles, Diana M DM
Publication Date: 2018-02

Variant appearance in text: BRCA2: 4106delC
PubMed Link: 29337092
Variant Present in the following documents:
  • mmc1.pdf
View BVdb publication page